We are proud of the accolades Raymond James continues to receive for its equity research. The recognition underscores the advantage of working with a firm such as Raymond James – one that values diligent analysis and prudent foresight.
This year, the Raymond James Equity Research department received 16 awards in the 2017 Thomson Reuters Analyst Awards for their stock selection and estimate accuracy on U.S. companies in industries ranging from information technology and communications to healthcare and pharmaceuticals. These awards are indicative of the deep industry knowledge, expertise and talent driving Raymond James Equity Research.
The firm now ranks fourth among all brokers in the U.S. and has been ranked in the top five in the U.S. over the past three- and five-year periods.
“Our Equity Research team works diligently to develop and share superior industry insight with our clients,” said Brian Alexander, director of Equity Research. “Our continued recognition from the Thomson Reuters Analyst Awards is further confirmation of the unprecedented expertise and ability behind our research.”
The Thomson Reuters Analyst Awards are recognized as the gold standard in objective measurement of sell-side analyst performance. Performance of analysts is measured in two ways: by the returns of their buy/sell recommendations and the accuracy of their earnings estimates. A detailed listing of methodology can be found on the Thomson Reuters Analyst Awards website.
If you would like to learn more about these awards, including how your portfolio may benefit from leveraging our award-winning equity research, please contact us any time.
Based on StarMine methodology, the Thomson Reuters Analyst Awards objectively measure the performance of analysts in two ways: by the returns of their buy/sell recommendations and the accuracy of their earnings estimates. The 2017 stock picking awards for the United States are based on the 2016 calendar-year performance of recommendations. The 2017 awards for estimating accuracy are based on quarterly periods that reported between April 1,2016 and 31 March 31, 2017. Only analyst performance on companies that are based in the United States is included in the awards calculations